Influence of patient characteristics on provider deviation from guideline-directed medical therapy of heart failure with reduced ejection fraction in primary care clinics

Authors

  • Karlyn Nieto University of North Texas HSC College of Pharmacy
  • Rachel Basinger TTUHSC - JHH School of Pharmacy
  • Rodney Young TTUHSC-School of Medicine, Department of Family Medicine
  • Tarek Naguib TTUHSC-School of Medicine, Department of Medicine
  • Eric MacLaughlin TTUHSC - JHH School of Pharmacy

Keywords:

HFrEF, Heart failure with reduced ejection fraction, GDMT, Guideline based treatment

Abstract

Background: Heart failure with reduced ejection fraction (HFrEF) is a significant cause of morbidity and mortality in the United States. Although data have demonstrated that guideline-directed medical therapy (GDMT) improves clinical outcomes, hospitalizations, and death due to HFrEF remain common.

Objective: To identify GDMT gaps for patients with HFrEF.

Methods: This retrospective cohort study evaluated adults with HFrEF at an academic internal medicine (IM) or family medicine (FM) clinic between 1/1/2018 and 2/29/2020. A chart review was conducted to characterize patient demographics, characteristics, and GDMT. Descriptive statistics and chi-squared tests were used to describe GDMT regimens and factors associated with improved guideline adherence.

Results: A total of 596 patients were evaluated and 96 included. Overall, 20% of patients were prescribed three GDMT agents (β-blocker+angiotensin converting enzyme inhibitor [ACEi]/angiotensin receptor blocker [ARB]/angiotensin receptor-neprilysin inhibitor [ARNI]+mineralocorticoid receptor antagonist [MRA]), 43.8% two agents (β-blocker + ACEi/ARB/ARNI), 27% one agent, and 9% no GDMT. Those with a payor status defined as commercial insurance were more likely to be on three GDMT agents than those with no commercial insurance (34.8% vs. 15.1%; p=0.039). Patients ≥65 years were less likely to be on three agents compared to those <65 years (8.3% vs. 32%, p=0.029), but more likely to be on a combination of a β-blocker+ACEi/ARB/ARNI (52.8% vs. 32%, p=0.01) or a β-blocker+MRA (11% vs. 2%; p=0.044).

Conclusions: GDMT was underutilized in these academic clinics. Differences in provider prescribing were identified based on age and funding status. Differences in prescribing could be due to demographics or other factors.

Downloads

Download data is not yet available.

Published

06/06/2024

How to Cite

1.
Nieto K, Basinger R, Young R, Naguib T, MacLaughlin E. Influence of patient characteristics on provider deviation from guideline-directed medical therapy of heart failure with reduced ejection fraction in primary care clinics. WTJOM. 2024;2(1). Accessed July 16, 2024. https://westtexasjom.org/index.php/wtjm/article/view/30

Issue

Section

Pharmacotherapy Section